Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MYNZ is expected to report earnings to fall 63.68% to -279 cents per share on May 29
Q1'25
Est.
$-2.80
Q4'24
Missed
by $1.31
Q3'24
Missed
by $4.27
Q2'24
Missed
by $19.45
Q1'24
Missed
by $0.06
The last earnings report on April 01 showed earnings per share of -771 cents, missing the estimate of -640 cents. With 59.35K shares outstanding, the current market capitalization sits at 20.77M.